Max Robotics — Global Service Robot Directory + US Certification

About

Fumitaro Masaki is a pioneering roboticist whose research centers on continuum robotics for minimally invasive medical interventions, with a particular focus on bronchoscopy and urology. His major contributions lie in developing multi-section continuum robots capable of follow-the-leader motion, enabling precise navigation through complex anatomical pathways such as the peripheral lung and kidney. Masaki’s 2019 paper on a transbronchial biopsy catheter enhanced by a multisection continuum robot (32 citations) established a foundational approach to steerable, flexible tools for lung cancer diagnosis. His 2021 validation study (18 citations) demonstrated the clinical advantage of first-person view control, showing that physician operators could more effectively maneuver the robotic bronchoscope to peripheral lung targets compared to manual techniques. More recently, his 2025 work on conditional autonomy (4 citations) pushes toward semi-autonomous robotic navigation, addressing critical needs in lung cancer staging. Masaki’s research bridges engineering innovation and clinical translation, with his ureteroscope feasibility study (2023) extending his continuum robot designs to kidney interventions. His work is widely cited for its potential to improve safety, efficiency, and accessibility in transbronchial biopsies, making him a key figure in the evolution of robot-assisted minimally invasive surgery.